Endothelial mineralocorticoid receptor contributes to systolic dysfunction induced by pressure overload without modulating cardiac hypertrophy or inflammation

التفاصيل البيبلوغرافية
العنوان: Endothelial mineralocorticoid receptor contributes to systolic dysfunction induced by pressure overload without modulating cardiac hypertrophy or inflammation
المؤلفون: Ane M. Salvador, Mark Aronovitz, M. Elizabeth Moss, Pilar Alcaide, Iris Z. Jaffe, Kathleen B. Mueller, Robert M. Blanton
المصدر: Physiological Reports
بيانات النشر: John Wiley and Sons Inc., 2017.
سنة النشر: 2017
مصطلحات موضوعية: 0301 basic medicine, Cardiac function curve, Cardiovascular Conditions, Disorders and Treatments, Male, medicine.medical_specialty, Physiology, Cardiac fibrosis, Systole, Immunology, heart failure, Inflammation, Blood Pressure, Cardiomegaly, 030204 cardiovascular system & hematology, Biology, Proinflammatory cytokine, Signalling Pathways, 03 medical and health sciences, chemistry.chemical_compound, Mice, 0302 clinical medicine, Mineralocorticoid receptor, Physiology (medical), Internal medicine, medicine, Ventricular Dysfunction, Animals, Cells, Cultured, Original Research, mineralocorticoid receptor, Pressure overload, Aldosterone, Ventricular Remodeling, Tumor Necrosis Factor-alpha, medicine.disease, Intercellular Adhesion Molecule-1, Fibrosis, Mice, Inbred C57BL, 030104 developmental biology, Endocrinology, Receptors, Mineralocorticoid, chemistry, Heart failure, Cardiology, endothelial cell, Endothelium, Vascular, medicine.symptom, Adhesion molecules
الوصف: Heart Failure (HF) is associated with increased circulating levels of aldosterone and systemic inflammation. Mineralocorticoid receptor (MR) antagonists block aldosterone action and decrease mortality in patients with congestive HF. However, the molecular mechanisms underlying the therapeutic benefits of MR antagonists remain unclear. MR is expressed in all cell types in the heart, including the endothelial cells (EC), in which aldosterone induces the expression of intercellular adhesion molecule 1 (ICAM‐1). Recently, we reported that ICAM‐1 regulates cardiac inflammation and cardiac function in mice subjected to transverse aortic constriction (TAC). Whether MR specifically in endothelial cells (EC) contributes to the several mechanisms of pathological cardiac remodeling and cardiac dysfunction remains unclear. Basal cardiac function and LV dimensions were comparable in mice with MR selectively deleted from ECs (EC‐MR −/−) and wild‐type littermate controls (EC‐MR +/+). MR was specifically deleted in heart EC, and in EC‐containing tissues, but not in leukocytes of TAC EC‐MR −/− mice. While EC‐MR −/− TAC mice showed preserved systolic function and some alterations in the expression of fetal genes, the proinflammatory cytokine TNF α and the endothelin receptors in the LV as compared to EC‐MR +/+ TAC mice, no difference was observed between both TAC groups in overall cardiac hypertrophy, ICAM‐1 LV expression and leukocyte infiltration, cardiac fibrosis or capillary rarefaction, all hallmarks of pathological cardiac remodeling. Our data indicate that EC‐MR contributes to the transition of cardiac hypertrophy to systolic dysfunction independently of other maladaptive changes induced by LV pressure overload.
اللغة: English
تدمد: 2051-817X
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18e89ab9b16f31c4e365eb26f13c91c6Test
http://europepmc.org/articles/PMC5492203Test
حقوق: OPEN
رقم الانضمام: edsair.doi.dedup.....18e89ab9b16f31c4e365eb26f13c91c6
قاعدة البيانات: OpenAIRE